Effect of drug treatment on bone mineral density and bone metabolism in patients with newly diagnosed hyperthyroidism

Pei-xian WU,Fan ZHANG,Wei LAN,Ya-li DAI,Shui CHEN,Jie HUAN,Min YE
DOI: https://doi.org/10.3969/j.issn.1672-3619.2016.11.014
2016-01-01
Abstract:Objective To evaluate the effect of medical treatment on bone mineral density(BMD) and bone metabolism in newly diagnosed hyperthyroidism subjects. Methods 32 cases of newly diagnosed hyperthyroidism patients in our hospital from January 2014 to March were selected as hyperthyroidism group;30 cases of age and sex-matched healthy people were selected as control group. Serum alkaline phosphatase (ALP), calcium, three free triiodothyronine (FT3), free thyroxine (FT4), thyroid stimulating hormone (TSH), serum osteocalcin (N-MID), β-collagen specific sequence (β-CTX) and total amino-terminal extension of type I collagen peptides (PINP) and femoral neck bone mineral density (BMD) before and after treatment were measured and analyzed. Results Hyperthyroid patients serum ALP, calcium, β-CTX, N-MID and PINP were significantly higher than normal control group (P<0.05).After treatment, serum ALP, calcium, β-CTX, N-MID and PINP were significantly lower than before treatment (P<0.05),but compared with the normal group, N-MID and PINP were still higher(P<0.05).Hyperthyroidism femoral neck BMD was significantly lower than that of normal (P<0.05),but was significantly increased after treatment (P<0.05).However, compared with the control group, BMD of hyperthyroidism group after treatment remained significantly lower (P<0.05). PINP, β-CTX, FT3 and N-MID showed a positive correlation with FT4, and negatively correlated with TSH (P<0.05); N-MID and femoral neck BMD was negatively correlated (P<0.05). Conclusion Positive antithyroid therapy could effectively reduce bone formation and resorption marker levels,and prevent the emergence of high-turnover osteoporosis.
What problem does this paper attempt to address?